GenMark Diagnostics (GNMK) reported a fourth quarter loss of $0.15 per share after the close Tuesday, compared to the loss of $0.27 per share last year. The consensus estimate was for a loss of $0.21.
GenMark Diagnostics gapped up Wednesday and climbed during the first hour of trade, before settling into a range. Shares finished with a gain of 1.11 at $12.16 on above average volume. The stock rose above a 2-month range and set a new high for the year.
For comments and feedback: editorial@rttnews.com